Summary:
- The National Cancer Institute (NCI) has stated that rescheduling cannabis under federal law could boost scientific research on the potential medical benefits of the plant, particularly in the field of cancer treatment.
- The NCI's comments were made in a newsletter published in October 2024, suggesting that the rescheduling of cannabis could lead to increased opportunities for researchers to study the plant's therapeutic properties.
- The newsletter highlights the potential for cannabis-based therapies to be explored as part of the NCI's efforts to advance cancer research and treatment options.